focus -WSS

focus

author：fashion 2025-08-11 16:25:02 - browse：515

Adobe

A month after announcing it was seeking strategic alternatives, Akili Interactive, maker of a video game designed to treat ADHD, said it will go private in a merger with Virtual Therapeutics. The deal is expected to net Akili’s shareholders $34 million.

Akili made headlines in 2020 when it received Food and Drug Administration clearance for EndeavorRx, a video game designed to treat pediatric ADHD. Akili went public in 2022 in a deal that valued the company at about $1 billion. But despite several strategic pivots, including shifting to direct-to-consumer sales, the company failed to build a sustainable business model. Akili in April announced it would wind down its existing commercial operations and focus on a licensing deal with Japanese pharma company Shionogi while it figured out the best path forward.

Akili is just one of many health tech companies that are struggling following an explosion of investor interest in digital health during the Covid-19 pandemic. In the last month alone, Better Therapeutics, another company making digital treatments, sold its assets for an undisclosed amount after failing to build a business around its app for type 2 diabetes, and Cue Health, a diagnostics startup, shut down after funding interest in its Covid-19 tests evaporated.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： NIH fellows want a pay raise. Will that mean less money for grants?

leisure time

WSS

How generative AI ratchets up security threats for health systems

Merck, Johnson & Johnson CEOs will testify on high drug prices

N.Y. state detects polio case, first in the U.S. since 2013

Charles Manson follower Leslie Van Houten released from prison after 53 years

Why Medicare shouldn’t cover every FDA

Leqembi, other new Alzheimer’s drugs require better biomarkers

Wikipedia

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

N.Y. state detects polio case, first in the U.S. since 2013

Hepatitis C has a cure — but many Americans still lack access to it

Zyn nicotine pouches become unlikely player in latest culture war

The cancer drug shortage isn’t new — and neither are the solutions

HCA discloses massive data breach affecting 11 million patients

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Vertex, Pfizer, Kura, and other biotech news

Wildfire smoke exposes gaps in outdoor worker protections

Bulgari apologizes to China for listing Taiwan as a country after online backlash

entertainment

Lecanemab for Alzheimer's is coming. Is the health system ready?

Bernie Sanders is gearing up to subpoena pharma CEOs

Charles Manson follower Leslie Van Houten released from prison after 53 years

It's time to get medical device identifiers over the finish line

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

10 reasons why health care startups fail

explore

entertainment

leisure time

explore